111 Inc ADR Down 8.26% To $1.97 After Earnings

Thursday, November 30, 2023 - 111 Inc ADR (YI) reported downside earnings and upside revenues.

111 Inc ADR earnings per share (EPS) came in at loss of $0.12 per share. 111 Inc ADR's earnings were down 20% year-over-year as the firm reported an EPS loss of $0.10 per share in its year-ago quarter. The negative annual growth shows the Consumer Defensive company isn't performing well amid current economic conditions.

111 Inc ADR Q3 2023 revenue came in at $502.4 million. The company achieved 7% growth year-over-year compared to the firm's revenue of $470.8 million from the year-ago quarter. The lower earnings growth relative to revenue signals 111 Inc ADR has not been able to improve its profit margin.

The stock is down 8.26% to $1.97 after the report.

111 Inc ADR's earnings expanded faster than revenues, signaling widening profit margins.

Trading in the five days leading up to the report earned 111 Inc ADR a Bearish Sentiment Rank from InvestorsObserver.

Prior to the report, InvestorsObserver gave the stock an overall score of 21.

111 Inc is engaged in online retail and wholesale pharmacy. It operates an integrated online and offline platform in the healthcare ecosystem in China. It is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in China. It manages operations into two segments: the B2C segment and the B2B segment. The B2B segment generates the vast majority of its revenue.